Drug intelligence / Profile preview

Morus rubra pollen extract

Development stage
Unknown
Lead developer
Jubilant HollisterStier
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Intradermal, Percutaneous, Subcutaneous
01

Overview

Morus rubra pollen extract is a biological, non-standardized allergenic extract derived from the pollen of the red mulberry tree (*Morus rubra*). [1, 4, 10] It is indicated for both the diagnosis (via skin testing) and treatment (via allergen immunotherapy) of individuals with immediate hypersensitivity (Type I allergy) to red mulberry pollen. [2, 3, 5, 10] In sensitized individuals, exposure to the pollen can cause respiratory allergies including allergic rhinitis, allergic rhino-conjunctivitis, and asthma. [1, 5, 6] As a diagnostic tool, the extract is administered percutaneously or intradermally to elicit a localized wheal-and-flare reaction. [2, 3] As immunotherapy, the extract is administered subcutaneously in gradually increasing doses to desensitize the patient's immune system and induce immunologic tolerance. [2, 3]

Brand names
Morus Rubra Pollen
Other names
Mulberry RedRed mulberry pollen extract
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Morus rubra pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Morus rubra pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call